1. Home
  2. /
  3. reviews
  4. /
  5. newsletters
  6. /
  7. Steve Jobs’ Final Prophecy – What Was His Last Prediction?

Steve Jobs’ Final Prophecy – What Was His Last Prediction?

Chris Dios - April 16, 2022

steve jobs' final prophecy hidden alpha
The Stock Dork is reader supported. We may earn a commission, at no additional cost to you if you buy products or signup for services through links on our site.

In his latest presentation, Joel Litman reveals that the Apple founder’s last predictions could be coming true right before our eyes, and it could be a tremendous opportunity for investors. Read our Steve Jobs’ Final Prophecy review to get the full story on this promising trend.

steve jobs' final prophecy

Steve Jobs’ Final Prophecy and Prediction

Shortly before his untimely passing, famed Apple founder Steve Jobs made a prediction about the future of the US technology industry.

Today, we’re seeing signs that he may have been right, and the resulting shift could have a tremendous impact on every corner of the global economy.

Before we dig into the specifics, let’s take a closer look at Steve Jobs to see why his prediction holds so much weight. 

>> Click here to get the Steve Jobs’ Final Prophecy deal for 75% off <<

Who Is Steve Jobs?

Steve Jobs was a visionary entrepreneur with keen foresight. Today, the tiny company he founded in his garage is worth upwards of $1 trillion.

Steve Jobs’ visionary status was earned by his uncanny ability to anticipate the future of tech and other fields.

He accurately predicted many of the most consequential inventions and investment trends of recent memory, including the advent of cloud computing, the development of laptops, Siri and Alexa voice assistants, and smartphones.

Over many years in the entrepreneurial spotlight, Jobs developed a cult-like following, and he’s hailed as a genius to this day for his insight and cunning.

Jobs was the driving force behind several technological advancements that wowed users and even his competitors.

His company, Apple, was behind the first successful mass-produced computers with a graphical user interface. Since then, it’s been a leading computer manufacturer, as well as an innovator in a variety of technologies.

Shortly before his tragic death, Job’s final prediction was still years away from becoming reality. He predicted that two of the world’s most cutting-edge industries would soon intersect to form an entirely new field: SynBio.

At the time, Jobs’ prediction drew little attention…

But now, his vision is rapidly becoming a reality, and many are taking notice.

In fact, Hidden Alpha’s Joel Litman is bringing this unfolding phenomenon to his follower’s attention with his Steve Jobs’ Final Prophecy presentation.

We’re going to break down everything you need to know about this deal in this review, so stay with us. But first, let’s take a deeper dive into the people behind the service.

hidden alpha reviews

What Is Hidden Alpha?

Hidden Alpha is a research service and monthly newsletter from Altimetry and forensic accounting specialist Joel Litman.

Altimetry is a research firm and sister company to Empire Financial Research, publishers of Empire Financial Daily.

The service primarily focuses on promising, undervalued large-cap stocks that Litman has identified through extensive financial analysis.

We have an in-depth Hidden Alpha review, but it’s not required reading for this package.

Hidden Alpha members also enjoy a wide array of additional benefits, including new stock recommendations every month, access to a complete model portfolio, and more.

If you sign up under the Steve Jobs’ Final Prophecy deal, you get a 12-month subscription to Hidden Alpha with your purchase, and it includes the full assortment of member benefits.

Hidden Alpha is a great service backed by a top-rate team. It’s an excellent addition to the Jobs’ Final Prophecy bundle, and it will keep you busy with monthly stock picks for a full year.

>> Save 75% when you join Hidden Alpha with this limited-time deal <<

Joel Litman reviews

Who Is Joel Litman?

Joel Litman is a seasoned finance veteran and one of the world’s leading forensic accounting experts. Litman leads the Hidden Alpha service and serves as its chief advisor.

Litman’s expertise is a valuable asset for Hidden Alpha readers. He has a knack for pinpointing promising large-cap stocks that the mainstream market has overlooked, and members get first-hand access to his latest findings.

Throughout his career, Litman has built a solid track record and earned widespread respect in his field.

Today, he serves as the Chief Investment Strategist for Hidden Alpha’s publisher, Altimetry, and he holds the title of CEO and President at Atimetry’s parent company, Valens Research.

Litman has appeared on CNBC, and Barron’s and Institutional Investor have both quoted him in their articles. He’s even been published in the Harvard Business Review!

Joel Litman is a qualified guru with a stellar resume. When he offers his opinions on the market, it’s usually worth listening to, and he sees a big opportunity developing that could prove Jobs’ last prediction correct.

>> Join now to access exclusive research from Joel Litman <<

Steve jobs quote and steve jobs words of inspiration

Steve Jobs’ Last Prediction: A SynBio Boom

The last words that Steve Jobs shared about the intersection of technology and biology seem to be coming true. The first major milestone came in January 2020 when researchers remotely sequenced the virus responsible for the COVID-19 pandemic.

Researchers used this digital model to isolate the spike protein that would eventually be used to develop an mRNA vaccine to prevent the disease.

Litman believes this underreported event marked the beginning of a new era centered around collaboration between technology and biology.

He calls this new industry SynBio, and he believes it could have an enormous impact on the entire global economy and fuel a new era of growth.

>> Get the full story on Steve Job’s final prophecy in these special reports <<

The Case for SynBio

SynBio could be the biggest thing since the internet, which launched the tech boom. Like the internet, SynBio could transform the entire economic landscape and fuel a new era of growth.

The implications could be enormous. Some examples of potential technologies include self-healing rubber, humane animal-based insulin, and much more.

Now could be a great time to get in on this under-the-radar tech, especially while much of the market is still stuck on 5G, electric cars, space exploration, self-driving cars, artificial intelligence, virtual reality, etc. 

Don’t get us wrong, EVs, AI, and the lot are fantastic, but they’re technologies dominating today’s headlines: everyone is already in the know. Some of the biggest investment gains come from getting in before the boom.

SynBio tech has endless potential and, just as Steve Jobs predicted, it could revolutionize the world. As it was with the last tech boom, early investors could see massive returns.

Opportunities Everywhere?

The best opportunities lie in stocks that are pioneering game-changing SynBio technology and building next-gen ecosystems like Amazon and Facebook.

With so many tech stocks crashing, many folks are looking for a new angle on the market. And SynBio could be the next big boom.

Joel Litman has identified several companies trading on the stock market right now that could dominate their industries in the years ahead.

He has assembled his work into a collection of exclusive reports as part of his Steve Jobs’ Final Prophecy bundle for Hidden Alpha. Altogether, they feature five of his top-rated SynBio stocks. 

During his presentation, he also shared one of his top-rated picks in the sector for free. Here are the details on Litman’s number-one SynBio stock.

Illumina stock price increase

Joel Litman’s #1 SynBio Stock

Joel Litman revealed that Illumina (ILMN) is one of his highest-rated SynBio stocks. This company has the most powerful DNA sequencing technology around.

Illumina controls roughly 90% of the market for gene-sequencing machines, and its business is growing at a break-neck pace. The firm grew its customer base by 50% in 2020, and revenues grew 25% in Q4 2021.

In addition to its lucrative gene sequencing business, Illumina also has a venture capital arm that actively pursues new ways for the company to expand and improve its market position.

Litman recommends Illumina as a buy for up to $510 per share to ensure you get the best possible upside.

Now, let’s take a look at the other bonuses included with the Steve Jobs’ Final Prophecy bundle.

>> Get Joel’s best SynBio stock picks when you join Hidden Alpha today <<

hidden alpha steve jobs final prophecy review

Steve Jobs’ Final Prophecy Review: What’s Included?

  • 12 months of Hidden Alpha investment research service
  • Updates and alerts from investing legend Joel Litman
  • Full access to the Hidden Alpha model portfolio
  • Litman’s SynBio special research reports:
  • FEATURED: My Favorite SynBio Investment Right Now
  • Profiting From the NEXT Big SynBio Wave
  • Buy the Platforms—Your Best Shot at a 1,000% Winner
  • The Perfect Portfolio
  • BONUS Subscription to Altimetry Daily Authority daily newsletter
  • Full access to Joel Litman’s research archives
  • 100% Money-back guarantee for 30 days

Hidden Alpha Newsletter

If you sign up for Joel Litman’s SynBio bundle, you also get a 12-month subscription to his monthly newsletter and research service, Hidden Alpha.

As a Hidden Alpha member, you’ll get Joel Litman’s latest stock picks, research, and analysis in your inbox on the first Monday of every month.

Litman keeps you informed on all the latest market-moving news, and you’ll be the first to know if he discovers another promising SynBio stock.

Updates and Alerts

Joel Litman sends out alerts whenever it’s time to make a move. You’ll receive both buy and sell alerts as part of your Hidden Alpha subscription.

You’ll also receive updates on the stocks featured in Joel Litman’s model portfolio so you can stay up to speed on each recommendation’s progress.

Hidden Alpha Model Portfolio

Your Hidden Alpha membership also includes unlimited access to Joel Litman’s model portfolio that features his active stock recommendations.

The model portfolio includes details on each recommended stock, including its name, ticker symbol, price target, and more.

You can quickly check up on the status of Litman’s stock picks with this handy resource, and it provides a bird’s-eye view of the entire Hidden Alpha stock picks portfolio.

>> Get unlimited access to Joel Litman’s model portfolio with Hidden Alpha <<

steve jobs final prophecy special reports

Steve Jobs’ Final Prophecy Review: Special Research Reports

This bundle includes exclusive special reports focusing on highly rated SynBio stocks. Here’s what’s covered in each brief:

FEATURED: My Favorite SynBio Investment Right Now

The featured report in the Steve Jobs’ Final Prophecy collection includes in-depth analysis of Joel Litman’s favorite SynBio play, Illumina.

As covered above, this company is a leading player in the DNA sequencing industry, and it has demonstrated tremendous promise over the past couple of years.

This report includes complete trading instructions that will help you get the most out of the potential opportunity in Illumina.

It also includes a list of stocks you should avoid that could be negatively impacted by the rise of SynBio. If you own one of these companies, this report could save you from substantial losses.

Profiting From the NEXT Big SynBio Wave

Buying Illumina is just one way to play the SynBio boom. According to Litman, buying the next big wave of winners is another important part of the strategy.

Litman has identified two smaller-cap SynBio stocks that could have tremendous upside, and he laid out his findings in this bonus report.

These overlooked stocks could experience a massive run-up as SynBio goes mainstream, and now could be a great time to get in close to the ground floor.

Buy the Platforms — Your Best Shot at a 1,000% Winner

The tech boom taught us that platforms like Facebook, Google, and Amazon can grow rapidly when a transformative trend takes off, and SynBio could be no exception.

Companies that create and host ecosystems that effectively harness SynBio innovations could be in the same class as the Big Tech behemoths that dominate today’s market.

This report features in-depth analysis of three promising stocks focused on SynBio platforms.

You probably haven’t heard of these companies just yet, but they could be household names before it’s all said and done.

>> Access Joel Litman’s top-rated SynBio stock picks when you sign up now <<

The Perfect Portfolio

Litman has assembled a mock portfolio featuring his top picks in the SynBio sector, and your Hidden Alpha subscription includes unlimited access to this valuable resource.

The portfolio showcases each stock’s name along with its ticker symbol, price target, current recommendation, and much more.

Litman’s Perfect Portfolio serves as an excellent model, and it can help you squeeze every drop of potential profits out of the SynBio revolution.

BONUS Subscription to Altimetry Daily Authority

If you sign up for the Steve Jobs’ Final Prophecy deal, you also get a bonus daily newsletter, Altimetry Daily Authority.

You’ll get an issue of this market daily newsletter every day ahead of the opening bell.

Between the monthly Hidden Alpha newsletter, updates from Joel Litman, and the Altimetry Daily Authority, you’ll have a constant stream of professional-grade research at your disposal.

Joel Litman’s Research Archives

You also get access to an archive containing the entire collection of Joel Litman’s research for Hidden Alpha, including his previous special reports and much more.

SynBio is today’s hot trend, but Litman has shared tons of valuable insights over the course of his tenure with Hidden Alpha. The archives give you first-hand access to all of it.

They are an excellent resource and valuable addition to Steve Jobs’ Final Prophecy deal.

>> Get instant access to Joel Litman’s COMPLETE research archives when you join NOW <<

Hidden Alpha refund policy

Money-Back Guarantee

Every Hidden Alpha subscription includes a 100% money-back guarantee from Joel Litman.

You have an entire 30 days to test drive the service and, if you don’t like it, you can get a full refund.

Simply contact the Hidden Alpha member services team within 30 days of your purchase and let them know you’re not satisfied. Then, they’ll issue a full refund for your subscription cost.

The money-back guarantee provides reassurance for anyone who has doubts about the service. Thirty days is plenty of time to decide if it’s a good fit, so you can subscribe with confidence.

Joel Litman’s SynBio Bundle: Pros and Cons

The Steve Jobs’ Final Prophecy bundle has ups and downs.

Here are all the pros and cons:

Pros

  • 3 In-depth research reports featuring 5 top-rated SynBio stocks
  • 12-month subscription to Hidden Alpha
  • Portfolio updates plus buy and sell alerts
  • Unlimited model portfolio access
  • Includes Litman’s Perfect Portfolio
  • Bonus market-daily Altimetry newsletter
  • New stock recommendations every month
  • 100% money-back guarantee
  • Affordably priced with a substantial discount

Cons

  • Doesn’t cover options, bonds, or futures
  • No community chat room

>> Sign up now to start enjoying these great benefits <<

How Much Does Hidden Alpha: Steve Jobs’ Final Prophecy Cost?

You can sign up under the Steve Jobs’ Final Prophecy deal at a substantially discounted rate.

Typically, a one-year subscription to Hidden Alpha costs $199, but our readers can access a special reduced rate.

If you sign up now, you’ll pay just $49 for the complete Steve Jobs’ Final Prophecy bundle. That’s a 75% discount on the full sticker price.

Better yet, you’ll still get all the bonus reports covered in this review, including Joel Litman’s top-5 SynBio stock recommendations

hidden alpha pricing

Is Hidden Alpha: Steve Jobs’ Final Prophecy Worth It?

Hidden Alpha is a great monthly research service in its own right, but the Steve Jobs’ Final Prophecy bundle is a downright bargain. You get a full year of Hidden Alpha, plus a treasure trove of additional research.

Joel Litman’s top-rated SynBio stocks and his Perfect Portfolio could put you in an excellent position to see enormous returns from this unfolding tech trend.

With monthly newsletters, regular updates, and a bonus market daily e-letter, you have an arsenal of investing insights from top-rated experts at your disposal every time the market is in session.

Plus, Litman’s forensic accounting expertise is an asset to every Hidden Alpha member. He has a solid track record and a stellar set of financial credentials, so you’re in good hands with him leading the charge.

Last but not least, the included 75% discount and 30-day money-back guarantee ensure you’ll walk away from this purchase satisfied, or you can get a full refund on your subscription.

Just as Steve Jobs’ Final Prophecy predicted, SynBio could be an enormous growth industry, and this package equips you to make the most of the opportunity.

>> Get started with Steve Jobs’ Final Prophecy now for just $49 <<

 

mm

Chris Dios is an American writer and entrepreneur from New Jersey. Chris began investing back in 2018, and he specializes in swing trading, fundamental analysis, and long-term investing.